Literature DB >> 1082325

Coexistent lymphoid interstitial pneumonia, pernicious anemia, and agammaglobulinemia.

A I Levinson, P C Hopewell, D P Stites, L E Spitler, H H Fudenberg.   

Abstract

Immunologic factors have been incriminated in the pathogenesis of lymphoid interstitial pneumonia. The discovery of a patient with coexistent lymphoid interestitial pneumonia, pernicious anemia, and common variable hypogammaglobulinemia focused attention on the possible autoimmune nature of this pulmonary disease. Extensive immunologic studies demonstrated a noticeably impaired bonemarrow-dependent (B cell) system and intact thymus-dependent (T cell) system. No evidence of humoral or cellular hypersensitivity to homologous lung determinants was found.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082325

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

Review 1.  Non-neoplastic pulmonary lymphoid lesions.

Authors:  W D Travis; J R Galvin
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  Pulmonary pathology in AIDS: atypical Pneumocystis carinii infection and lymphoid interstitial pneumonia.

Authors:  M J Saldana; J M Mones
Journal:  Thorax       Date:  1994       Impact factor: 9.139

3.  Exploration of the pulmonary circulation. Festschrift to Professor Donald Heath.

Authors: 
Journal:  Thorax       Date:  1994       Impact factor: 9.139

4.  Lymphocytic interstitial pneumonitis in HIV infected adults.

Authors:  S Das; R F Miller
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

Review 5.  Follicular Bronchiolitis: A Literature Review.

Authors:  Basheer Tashtoush; Ndubuisi C Okafor; Jose F Ramirez; Laurence Smolley
Journal:  J Clin Diagn Res       Date:  2015-09-01

Review 6.  Granulomatous-Lymphocytic Interstitial Lung Disease in 22q11.2 Deletion Syndrome: a Case Report and Literature Review.

Authors:  Amika K Sood; William Funkhouser; Brian Handly; Brent Weston; Eveline Y Wu
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-22       Impact factor: 4.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.